CORRECTED-Roche's Tecentriq boosts survival in triple-negative breast cancer

An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.

https://ift.tt/2R2ONO3 support@endlesssupplies.biz (Endless Supplies .Biz) October 20, 2018 at 10:51AM